HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$1.95
Day range
$1.82 - $2.03
Year range
$1.78 - $39.00
Market cap
3.05M USD
Avg Volume
44.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.90M | 17.43% |
Net income | -2.68M | -143.54% |
Net profit margin | — | — |
Earnings per share | -2.52 | 83.37% |
EBITDA | -1.90M | -17.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.55M | -17.80% |
Total assets | 14.70M | -18.86% |
Total liabilities | 5.23M | -35.46% |
Total equity | 9.47M | — |
Shares outstanding | 1.63M | — |
Price to book | 0.34 | — |
Return on assets | -35.34% | — |
Return on capital | -59.00% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.68M | -143.54% |
Cash from operations | -2.84M | -80.17% |
Cash from investing | -19.17K | — |
Cash from financing | 5.42M | -61.37% |
Net change in cash | 2.56M | -79.44% |
Free cash flow | -1.45M | -158.07% |
About
Founded
2019
Website
Employees
9